SELLAS Life Sciences Group (SLS) Income from Continuing Operations: 2010-2023
Historic Income from Continuing Operations for SELLAS Life Sciences Group (SLS) over the last 9 years, with Dec 2023 value amounting to -$37.9 million.
- SELLAS Life Sciences Group's Income from Continuing Operations rose 13.43% to -$8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year increase of 9.73%. This contributed to the annual value of -$37.9 million for FY2023, which is 8.31% up from last year.
- According to the latest figures from FY2023, SELLAS Life Sciences Group's Income from Continuing Operations is -$37.9 million, which was up 8.31% from -$41.3 million recorded in FY2022.
- In the past 5 years, SELLAS Life Sciences Group's Income from Continuing Operations ranged from a high of -$16.8 million in FY2020 and a low of -$41.3 million during FY2022.
- Moreover, its 3-year median value for Income from Continuing Operations was -$37.9 million (2023), whereas its average is -$33.3 million.
- Per our database at Business Quant, SELLAS Life Sciences Group's Income from Continuing Operations rose by 13.14% in 2020 and then plummeted by 99.53% in 2022.
- SELLAS Life Sciences Group's Income from Continuing Operations (Yearly) stood at -$19.3 million in 2019, then climbed by 13.14% to -$16.8 million in 2020, then fell by 23.52% to -$20.7 million in 2021, then slumped by 99.53% to -$41.3 million in 2022, then rose by 8.31% to -$37.9 million in 2023.